Accessibility Menu
Sinopharm Group logo

Sinopharm Group

(OTC) SHTDY

Current Price$10.78
Market Cap$2.89B
Since IPO (2016)-37%
5 Year-20%
1 Year-8%
1 Month-8%

Sinopharm Group Financials at a Glance

Market Cap

$2.89B

Revenue (TTM)

CN¥1.15T

Net Income (TTM)

CN¥14.13B

EPS (TTM)

$1.60

P/E Ratio

6.76

Dividend

$0.47

Beta (Volatility)

0.34 (Low)

Price

$10.78

Volume

43,640

Open

$10.79

Previous Close

$10.78

Daily Range

$10.77 - $10.81

52-Week Range

$10.57 - $14.87

Estimated Earnings Date

Apr 23, 2026

SHTDY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sinopharm Group

Industry

Healthcare Providers and Services

Employees

94,910

Headquarters

Shanghai, 200023, CN

SHTDY Financials

Key Financial Metrics (TTM)

Gross Margin

7%

Operating Margin

3%

Net Income Margin

1%

Return on Equity

9%

Return on Capital

11%

Return on Assets

2%

Earnings Yield

14.79%

Dividend Yield

4.36%

Payout Ratio

59.18%

Stock Overview

Market Cap

$2.89B

Shares Outstanding

268.36M

Volume

43.64K

Avg. Volume

86.27K

Financials (TTM)

Gross Profit

CN¥40.09B

Operating Income

CN¥16.21B

EBITDA

CN¥20.38B

Operating Cash Flow

CN¥14.14B

Capital Expenditure

-CN¥1.62B

Free Cash Flow

CN¥12.52B

Cash & ST Invst.

CN¥61.60B

Total Debt

CN¥108.65B

Sinopharm Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CN¥283.78B

-4.0%

Gross Profit

CN¥20.70B

-18.0%

Gross Margin

7.29%

N/A

Market Cap

$2.89B

N/A

Market Cap/Employee

$26.73K

N/A

Employees

108,217

N/A

Net Income

CN¥3.62B

-26.8%

EBITDA

CN¥11.06B

-18.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CN¥61.60B

-3.5%

Total Debt

CN¥108.65B

+47.3%

Accounts Receivable

CN¥206.78B

+11.3%

Inventory

CN¥63.38B

+5.6%

Long Term Debt

CN¥6.14B

-64.4%

Short Term Debt

CN¥102.51B

+81.3%

Return on Assets

1.83%

N/A

Return on Invested Capital

10.95%

N/A

Free Cash Flow

CN¥47.30B

-20.2%

Operating Cash Flow

CN¥48.25B

-20.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SSMXYSysmex Corporation
$8.74-2.67%
TRSBF3SBio Inc.
$2.20+0.00%
SHPMYShanghai Pharmaceuticals Holding Co., Ltd
$7.60+0.00%
WILLFDemant A/S
$35.45+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%
SMCISuper Micro Computer
$30.46-0.05%

Questions About SHTDY

What is the current price of Sinopharm Group?

Sinopharm Group is trading at $10.78 per share.

What is the 52-week range for Sinopharm Group?

Over the past 52 weeks, Sinopharm Group has traded between $10.57 and $14.87.

How much debt does Sinopharm Group have?

As of the most recent reporting period, Sinopharm Group reported total debt of CN¥14.35B.

How much cash does Sinopharm Group have on hand?

Sinopharm Group reported CN¥8.43B in cash and cash equivalents in its most recent financial results.

What is Sinopharm Group’s dividend yield?

Sinopharm Group currently has a dividend yield of 4.36%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.